-Frontline   The Supreme Court's ruling against Novartis' patent claim for the cancer drug Glivec paves the way for generic drug companies to keep crucial, life-saving drugs affordable to the common people. By V. VENKATESAN IN their 112-page judgment delivered on April 1, Justice Aftab Alam and Justice Ranjana Prakash Desai of the Supreme Court began with a simple proposition: in order to understand what the law really is, it is essential to...

-The Telegraph Ranchi: Touching lives of many a rural artisan across the state, now Jharcraft is all set to strike a chord with craftswomen of Deoghar, Kharsawan and Ranchi district with new silk ventures. In a bid to tap the potential of sericulture in the hinterland, Jharcraft will soon set up three silk farms for the first time. It has already acquired five acres each at Jasidih industrial area in Deoghar and...

-Outlook Bhubaneswar: Odisha government has acquired 2,100 acres of land for the proposed mega steel project by Posco-India in Jagatsinghpur district. "State-owned Industrial Infrastructure Development Corporation (IDCO) has acquired 2,100 acres of land of which 546 acre had been handed over to Posco. Rest 1,554 acres is ready to be handed over to Posco," the status paper prepared by the state government said. Another 600 acres of land for the purpose was expected...

-The Indian Express On Monday, the Bengali new year's day, viewers who tuned into Bengali music channel Tara Muzik witnessed a spectacle never seen before on Indian TV. Anchors of the channel and independent artistes called in to present Barsha Baran, a programme to celebrate the new year 1420, wept copiously on camera while announcing that the channel, facing an unprecedented "crisis of survival", was shutting down. Hundreds of viewers commiserated with...

The recent Supreme Court judgment dismissing pharma giant Novartis’ claim for patent protections in India for its award-winning and prohibitively priced anti-leukemia drug Glivec has renewed the focus on accessibly-priced drugs – in particular the failure of the Indian public healthcare system and health policy to ensure affordable drugs for all. Studies show that as much as 70% of health spending in India comes from out-of-pocket payments, with 50-80% of...